Jpmorgan Chase & CO Opko Health, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Opko Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,836,868 shares of OPK stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,836,868
Previous 1,299,842
41.31%
Holding current value
$2.83 Million
Previous $1.62 Million
68.47%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding OPK
# of Institutions
255Shares Held
187MCall Options Held
6.03MPut Options Held
10.1M-
Rubric Capital Management LP New York, NY48.7MShares$75 Million2.02% of portfolio
-
Black Rock Inc. New York, NY29.2MShares$45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.2MShares$45 Million0.0% of portfolio
-
State Street Corp Boston, MA8.72MShares$13.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA8.37MShares$12.9 Million0.0% of portfolio
About OPKO HEALTH, INC.
- Ticker OPK
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 771,960,000
- Market Cap $1.19B
- Description
- OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...